Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 09, 2016 10:23 AM ET

Healthcare Equipment and Supplies

Company Overview of EndoGastric Solutions, Inc.

Company Overview

EndoGastric Solutions, Inc., a medical device company, develops, markets, and sells natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. It offers EsophyX, a technology that enables transoral reconstructive surgery; SerosaFuse Fasteners, a non-resorbable polypropylene material product that have equivalent web strength to a 3.0 suture; trainer-led courses for surgeons; and consultative, support, pre-authorization, internal appeal, and external medical review services. The company was formerly known as EsophyX, Inc. and changed its name to EndoGastric Solutions, Inc. in 2005. EndoGastric Solutions, Inc. was founded in 2002 and is headquartered...

1900 O'Farrell Street

Suite 325

San Mateo, CA 94403

United States

Founded in 2002

Phone:

650-578-5100

Fax:

650-578-5101

Key Executives for EndoGastric Solutions, Inc.

Chief Executive Officer, President and Director
Age: 54
Chief Financial Officer
Age: 57
Director of Finance and Controller
Senior Director of US Sales
Compensation as of Fiscal Year 2015.

EndoGastric Solutions, Inc. Key Developments

EndoGastric Solutions Secures $50 Million in Financing

EndoGastric Solutions announced that it has secured additional new financing of up to $50.0 million, led by CRG (formerly Capital Royalty L.P.) and existing EGS investors including Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, Foundation Medical Partners, and Radius Ventures. EGS plans to use proceeds from the financing to begin broad-scale commercialization, as well as making further R&D investments in next generation products used in their TIF procedure.

EndoGastric Solutions Names Michael K. Burke as Chief Financial Officer

EndoGastric Solutions announced that industry veteran Michael K. Burke has been named Chief Financial Officer. Mr. Burke is a seasoned financial executive with over 30 years of experience. Mr. Burke has held several leadership positions in finance. He most recently served as Senior Vice President and Chief Financial Officer of Landauer, Inc. Prior to this, Mr. Burke was the Senior Vice President and Chief Financial Officer of Albany International Corp. and as the Executive Vice President and Chief Financial Officer of Intermagnetics General Corporation.

Endogastric Announces One-Year Clinical Data from the RESPECT Study

EndoGastric Solutions, Inc. announced updated one-year clinical data from the RESPECT (Randomized EsophyX® vs. Sham/Placebo Controlled Trial) study, the first-ever randomized, blinded, sham- and placebo-controlled study of the company's Transoral Incisionless Fundoplication (TIF®) procedure. The RESPECT study, along with a second separate study of health economic data comparing reflux treatment methods including the TIF procedure, will be presented at the American College of Gastroenterology (ACG) 2015 Annual Scientific Meeting, October 16- 21, 2015 in Honolulu, Hawaii. Eighty-seven patients were randomly assigned to the group that underwent the TIF procedure and then received an ongoing treatment of placebo medication. After more than 12 months, 72% reported elimination of troublesome regurgitation per Montreal consensus criteria. The study also found that the mean DeMeester Score decreased from 33.6 to 23.9 at 6 months and to 24.7 at > 12 months post-TIF (p < 0.05).

Similar Private Companies By Industry

Company Name Region
Draeger Safety Diagnostics, Inc. United States
American Thermocraft Corporation United States
Brimfield Precision, Inc. United States
iHEAR Medical, Inc. United States
Personics Holdings, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 12, 2015
--
Private Placement
April 10, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact EndoGastric Solutions, Inc., please visit www.endogastricsolutions.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.